Charles Schwab’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
65,929
-29,701
| -31% | -$767K | ﹤0.01% | 2721 |
|
|
2025
Q1 | $975K | Sell |
95,630
-2,114
| -2% | -$21.6K | ﹤0.01% | 2856 |
|
|
2024
Q4 | $1.36M | Buy |
97,744
+799
| +0.8% | +$11.1K | ﹤0.01% | 2803 |
|
|
2024
Q3 | $1.89M | Sell |
96,945
-2,237
| -2% | -$43.6K | ﹤0.01% | 2726 |
|
|
2024
Q2 | $1.84M | Buy |
99,182
+23,961
| +32% | +$446K | ﹤0.01% | 2727 |
|
|
2024
Q1 | $1.05M | Buy |
75,221
+2,293
| +3% | +$32.1K | ﹤0.01% | 2782 |
|
|
2023
Q4 | $618K | Buy |
72,928
+1,325
| +2% | +$11.2K | ﹤0.01% | 2989 |
|
|
2023
Q3 | $640K | Buy |
71,603
+4,934
| +7% | +$44.1K | ﹤0.01% | 2955 |
|
|
2023
Q2 | $575K | Sell |
66,669
-13,562
| -17% | -$117K | ﹤0.01% | 2980 |
|
|
2023
Q1 | $846K | Sell |
80,231
-11,515
| -13% | -$121K | ﹤0.01% | 2788 |
|
|
2022
Q4 | $3.11M | Buy |
91,746
+1,127
| +1% | +$38.2K | ﹤0.01% | 2420 |
|
|
2022
Q3 | $4.35M | Buy |
90,619
+3,309
| +4% | +$159K | ﹤0.01% | 2288 |
|
|
2022
Q2 | $4.98M | Buy |
87,310
+24,114
| +38% | +$1.37M | ﹤0.01% | 2187 |
|
|
2022
Q1 | $5.11M | Buy |
63,196
+1,138
| +2% | +$92K | ﹤0.01% | 2270 |
|
|
2021
Q4 | $12.6M | Buy |
62,058
+1,553
| +3% | +$315K | ﹤0.01% | 1881 |
|
|
2021
Q3 | $16.3M | Buy |
60,505
+1,087
| +2% | +$293K | 0.01% | 1731 |
|
|
2021
Q2 | $15.3M | Buy |
59,418
+1,324
| +2% | +$341K | 0.01% | 1764 |
|
|
2021
Q1 | $17.4M | Sell |
58,094
-8,663
| -13% | -$2.6M | 0.01% | 1632 |
|
|
2020
Q4 | $17M | Buy |
66,757
+3,295
| +5% | +$840K | 0.01% | 1517 |
|
|
2020
Q3 | $15.8M | Buy |
63,462
+1,556
| +3% | +$387K | 0.01% | 1369 |
|
|
2020
Q2 | $21.5M | Buy |
61,906
+6,125
| +11% | +$2.13M | 0.01% | 1115 |
|
|
2020
Q1 | $14.9M | Buy |
55,781
+3,557
| +7% | +$952K | 0.01% | 1194 |
|
|
2019
Q4 | $16.9M | Sell |
52,224
-17,771
| -25% | -$5.75M | 0.01% | 1329 |
|
|
2019
Q3 | $19.1M | Buy |
69,995
+19,951
| +40% | +$5.45M | 0.01% | 1170 |
|
|
2019
Q2 | $26.7M | Buy |
50,044
+1,834
| +4% | +$979K | 0.02% | 947 |
|
|
2019
Q1 | $24.3M | Buy |
48,210
+1,394
| +3% | +$703K | 0.02% | 986 |
|
|
2018
Q4 | $23.1M | Buy |
46,816
+1,725
| +4% | +$851K | 0.02% | 903 |
|
|
2018
Q3 | $41.2M | Sell |
45,091
-14,022
| -24% | -$12.8M | 0.03% | 630 |
|
|
2018
Q2 | $43.3M | Sell |
59,113
-18,103
| -23% | -$13.3M | 0.03% | 562 |
|
|
2018
Q1 | $123M | Buy |
77,216
+23,718
| +44% | +$37.8M | 0.1% | 203 |
|
|
2017
Q4 | $47.9M | Buy |
53,498
+6,613
| +14% | +$5.92M | 0.04% | 476 |
|
|
2017
Q3 | $16.9M | Buy |
46,885
+3,229
| +7% | +$1.16M | 0.01% | 1055 |
|
|
2017
Q2 | $12.8M | Buy |
43,656
+1,416
| +3% | +$415K | 0.01% | 1176 |
|
|
2017
Q1 | $14.9M | Buy |
42,240
+3,786
| +10% | +$1.33M | 0.01% | 1025 |
|
|
2016
Q4 | $7.08M | Buy |
38,454
+4,122
| +12% | +$759K | 0.01% | 1507 |
|
|
2016
Q3 | $8.85M | Buy |
34,332
+3,246
| +10% | +$837K | 0.01% | 1254 |
|
|
2016
Q2 | $6.64M | Buy |
31,086
+552
| +2% | +$118K | 0.01% | 1369 |
|
|
2016
Q1 | $6.3M | Sell |
30,534
-19
| -0.1% | -$3.92K | 0.01% | 1364 |
|
|
2015
Q4 | $7.72M | Buy |
30,553
+3,263
| +12% | +$825K | 0.01% | 1199 |
|
|
2015
Q3 | $4.49M | Sell |
27,290
-9,629
| -26% | -$1.58M | 0.01% | 1544 |
|
|
2015
Q2 | $6.93M | Buy |
36,919
+12,973
| +54% | +$2.43M | 0.01% | 1323 |
|
|
2015
Q1 | $3.95M | Sell |
23,946
-1,386
| -5% | -$229K | 0.01% | 1667 |
|
|
2014
Q4 | $5.89M | Sell |
25,332
-8,432
| -25% | -$1.96M | 0.01% | 1320 |
|
|
2014
Q3 | $6.11M | Buy |
33,764
+677
| +2% | +$123K | 0.01% | 1191 |
|
|
2014
Q2 | $6.36M | Sell |
33,087
-2,501
| -7% | -$481K | 0.01% | 1201 |
|
|
2014
Q1 | $6.47M | Buy |
35,588
+6,828
| +24% | +$1.24M | 0.01% | 1121 |
|
|
2013
Q4 | $4.9M | Sell |
28,760
-2,266
| -7% | -$386K | 0.01% | 1272 |
|
|
2013
Q3 | $4.87M | Buy |
31,026
+11,226
| +57% | +$1.76M | 0.01% | 1208 |
|
|
2013
Q2 | $3.55M | Buy |
+19,800
| New | +$3.55M | 0.01% | 1337 |
|